MARKET

KRYS

KRYS

Krystal Biotech
NASDAQ
235.80
-2.75
-1.15%
Closed 18:40 12/17 EST
OPEN
237.76
PREV CLOSE
238.55
HIGH
238.66
LOW
234.17
VOLUME
270.23K
TURNOVER
0
52 WEEK HIGH
248.60
52 WEEK LOW
122.80
MARKET CAP
6.84B
P/E (TTM)
35.39
1D
5D
1M
3M
1Y
5Y
1D
If You Invested $100 In Krystal Biotech Stock 5 Years Ago, You Would Have This Much Today
Benzinga · 2d ago
Weekly Report: what happened at KRYS last week (1208-1212)?
Weekly Report · 3d ago
Krystal Biotech And 2 Other Growth Stocks Insiders Are Betting On
Simply Wall St · 6d ago
Weekly Report: what happened at KRYS last week (1201-1205)?
Weekly Report · 12/08 10:24
Krystal Biotech President Suma Krishnan Reports Disposal of Common Shares
Reuters · 12/05 23:56
Krish S. Krishnan, President and CEO, Reports Disposal of Krystal Biotech Inc. Common Shares
Reuters · 12/05 23:54
Recursion Pharmaceuticals (RXRX) Up 6.5% Since Last Earnings Report: Can It Continue?
NASDAQ · 12/05 16:30
Here's How Much You Would Have Made Owning Krystal Biotech Stock In The Last 5 Years
Benzinga · 12/04 21:00
More
About KRYS
Krystal Biotech, Inc. is an integrated, commercial-stage biotechnology company. The Company is focused on the discovery, development, and commercialization of genetic medicines to treat diseases with high unmet medical needs. Its product candidates in various stages of clinical and preclinical development include KB407, KB408, KB707, KB105, KB801, KB803, KB304 and KB301. Its commercial product, VYJUVEK, is a redosable gene therapy, and a genetic medicine approved in the United States and Europe for the treatment of dystrophic epidermolysis bullosa. KB407 is being developed for the treatment of Cystic Fibrosis. KB408 is being developed for the treatment of Alpha-1 Antitrypsin Deficiency, a rare lung disease. KB707 is being developed for the treatment of solid tumors. KB105 is being developed for TGM1-Deficient Autosomal Recessive Congenital Ichthyosis. KB803 is a redosable eye drop formulation of B-VEC, designed for the treatment of ocular complications.

Webull offers Krystal Biotech Inc stock information, including NASDAQ: KRYS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KRYS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KRYS stock methods without spending real money on the virtual paper trading platform.